These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 3530075

  • 1. A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
    Joshi M, Fitzpatrick BJ, Warren JW, Caplan ES, Tenney JH.
    Am Surg; 1986 Sep; 52(9):467-71. PubMed ID: 3530075
    [Abstract] [Full Text] [Related]

  • 2. Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections.
    Sweet RL, Ohm-Smith M, Landers DV, Robbie MO.
    Am J Obstet Gynecol; 1985 Aug 01; 152(7 Pt 1):808-17. PubMed ID: 3895947
    [Abstract] [Full Text] [Related]

  • 3. A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections.
    Drusano GL, Warren JW, Saah AJ, Caplan ES, Tenney JH, Hansen S, Granados J, Standiford HC, Miller EH.
    Surg Gynecol Obstet; 1982 May 01; 154(5):715-20. PubMed ID: 7041297
    [Abstract] [Full Text] [Related]

  • 4. Moxalactam versus clindamycin plus tobramycin for the treatment of puerperal infections.
    Pastorek JG, Faro S, Aldridge KE, Nicaud SK.
    South Med J; 1987 Sep 01; 80(9):1116-9. PubMed ID: 3306943
    [Abstract] [Full Text] [Related]

  • 5. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
    Stromberg BV, Reines HD, Hunt P.
    Surg Gynecol Obstet; 1986 Jun 01; 162(6):575-8. PubMed ID: 3012808
    [Abstract] [Full Text] [Related]

  • 6. Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
    Stellato TA, Danziger LH, Hau T, Gauderer MW, Ferron JL, Gordon N.
    Arch Surg; 1988 Jun 01; 123(6):714-7. PubMed ID: 3285809
    [Abstract] [Full Text] [Related]

  • 7. Intravenous metronidazole or clindamycin with tobramycin for therapy of pelvic infections.
    Gall SA, Kohan AP, Ayers OM, Hughes CE, Addison WA, Hill GB.
    Obstet Gynecol; 1981 Jan 01; 57(1):51-8. PubMed ID: 7005778
    [Abstract] [Full Text] [Related]

  • 8. Treatment of intra-abdominal infections is appropriate with single-agent or combination antibiotic therapy.
    Malangoni MA, Condon RE, Spiegel CA.
    Surgery; 1985 Oct 01; 98(4):648-55. PubMed ID: 3901372
    [Abstract] [Full Text] [Related]

  • 9. Comparison of moxalactam with the combination of clindamycin and an aminoglycoside in the treatment of common surgical infections.
    Rambo WM, Del Bene VE, Burkey LG, Collins CD, Richmond DK.
    Rev Infect Dis; 1982 Oct 01; 4 Suppl():S683-7. PubMed ID: 6218583
    [Abstract] [Full Text] [Related]

  • 10. A prospective randomized study of moxalactam versus gentamicin and clindamycin in penetrating abdominal trauma.
    Kreis DJ, Augenstein D, Martinez O, Echenique M, Plasencia G, Vopal JJ, Byers P, Gomez GA.
    Surg Gynecol Obstet; 1986 Jul 01; 163(1):1-4. PubMed ID: 3726718
    [Abstract] [Full Text] [Related]

  • 11. Cost comparison of two antimicrobial regimens for treating mixed aerobic-anaerobic infections.
    Scheife RT, Tally FP, McGowan K, Gorbach SL.
    Am J Hosp Pharm; 1981 Oct 01; 38(10):1466-9. PubMed ID: 7294038
    [Abstract] [Full Text] [Related]

  • 12. Prospective, randomized comparison of the efficacy and safety of netilmicin-clindamycin and tobramycin-clindamycin in the treatment of serious systemic infections.
    Kahalley S, Chandler J, Hawkins J, Norris G, Waugespack R, Snow RM.
    Clin Ther; 1985 Oct 01; 7(4):497-506. PubMed ID: 4016829
    [Abstract] [Full Text] [Related]

  • 13. Ceftazidime/clindamycin versus tobramycin/clindamycin in the treatment of intra-abdominal infections.
    Bubrick MP, Heim-Duthoy KL, Yellin AE, Berne TV, Heseltine PN, Appleman MD, Cocchetto DM, Matzke GR.
    Am Surg; 1990 Oct 01; 56(10):613-7. PubMed ID: 2221611
    [Abstract] [Full Text] [Related]

  • 14. Use of cephalosporins with enhanced anti-anaerobic activity for treatment and prevention of anaerobic and mixed infections.
    DiPiro JT, May JR.
    Clin Pharm; 1988 Apr 01; 7(4):285-302. PubMed ID: 3284692
    [Abstract] [Full Text] [Related]

  • 15. Cefoxitin plus tobramycin and clindamycin plus tobramycin. A prospective randomized comparison in the therapy of mixed aerobic/anaerobic infections.
    Nicolle LE, Harding GK, Louie TJ, Thomson MJ, Blanchard RJ.
    Arch Surg; 1986 Aug 01; 121(8):891-6. PubMed ID: 3524511
    [Abstract] [Full Text] [Related]

  • 16. Diffuse peritonitis treated with tobramycin and clindamycin. Bacteria in relation to preoperative duration of illness.
    Lindblad B, Claesson B.
    Acta Chir Scand; 1983 Aug 01; 149(6):573-8. PubMed ID: 6359795
    [Abstract] [Full Text] [Related]

  • 17. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
    Feld R, Louie TJ, Mandell L, Bow EJ, Robson HG, Chow A, Belch A, Miedzinski L, Rachlis A, Pater J.
    Arch Intern Med; 1985 Jun 01; 145(6):1083-8. PubMed ID: 3890789
    [Abstract] [Full Text] [Related]

  • 18. Twice-daily moxalactam versus gentamicin and clindamycin in patients with penetrating abdominal trauma.
    Crots LD, Obeid FN, Horst HM, Bivins BA.
    Clin Pharm; 1985 Jun 01; 4(3):316-20. PubMed ID: 3891203
    [Abstract] [Full Text] [Related]

  • 19. Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.
    Tally FP, Kellum JM, Ho JL, O'Donnell TF, Barza M, Gorbach SL.
    Antimicrob Agents Chemother; 1986 Feb 01; 29(2):244-9. PubMed ID: 3717931
    [Abstract] [Full Text] [Related]

  • 20. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
    Fainstein V, Bodey GP, Bolivar R, Elting L, McCredie KB, Keating MJ.
    Arch Intern Med; 1984 Sep 01; 144(9):1766-70. PubMed ID: 6383246
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.